🔴 Noveris Health Sciences is trading 13.33% down today amid broad biotech weakness

Noveris Health Sciences is trading 13.33% down at $0.13 amid broad weakness in biotechnology.

• The XBI ETF was down 4.24% during the regular session.
• No new company-specific announcement was identified for August 31, 2026.
• The latest development remains a proposed C$500,000 convertible-debenture financing, announced August 20 and expected to close around August 28; it does not clearly explain today’s decline.